Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer

Published:2009-02-17 Issue:5 Volume:64 Page:917-924
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Chang Myung Hee,Kim Kyoung Ha,Jun Hyun Jung,Kim Hyo Song,Yi Seong Yoon,Uhm Ji Eun,Park Min Jae,Lim Do Hyoung,Ji Sang Hoon,Hwang In Gyu,Lee Jeeyun,Park Yeon Hee,Ahn Jin Seok,Ahn Myung-ju,Park Keunchil

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-009-0943-7.pdf

Reference34 articles.

1. Bae J, Gwack J, Park SK, Shin HR, Chang SH, Yoo KY (2007) Cigarette smoking, alcohol consumption, tuberculosis and risk of lung cancer: the Korean multi-center cancer cohort study. J Prev Med Pub Health 40:321–328

2. Cappuzzo F, Novello S, De Marinis F, Franciosi V, Maur M, Ceribelli A, Lorusso V, Barbieri F, Castaldini L, Crucitta E, Marini L, Bartolini S, Scagliotti GV, Crino L (2005) Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer. Br J Cancer 93:29–34

3. Cardenal F, Domine M, Massuti B, Carrato A, Felip E, Garrido P, Juan O, Artal A, Barneto I, Lopez-Vivanco G, Balcells M, Rosell R (2003) Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study. Lung Cancer 39:201–207

4. Chollet P, Bensmaine MA, Brienza S, Deloche C, Cure H, Caillet H, Cvitkovic E (1996) Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer. Ann Oncol 7:1065–1070

5. Cortinovis D, Bidoli P, Zilembo N, Fusi A, Bajetta E (2008) Oxaliplatin doublets in non-small cell lung cancer: a literature review. Lung Cancer 60:325–331

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC);Cancer Chemotherapy and Pharmacology;2013-09-22

2. Chemotherapy-Induced Peripheral Neuropathy;Chemotherapy-Induced Neuropathic Pain;2012-07-06

3. Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer;Investigational New Drugs;2009-05-15